Related Experiment Videos
Studies on 5'-methylthioadenosine uptake by human erythrocytes
Medical Biology
|December 1, 1981
Summary
Human red blood cells transport 5'-methylthioadenosine via a carrier mechanism. This process is distinct from metabolic trapping, especially in phosphate-rich environments where it is converted to 5-methylthioribose-1-phosphate.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- 5 -methylthioadenosine (MTA) is a molecule involved in various cellular processes.
- Understanding MTA transport in human erythrocytes is crucial for metabolic studies.
Purpose of the Study:
- To characterize the mechanism of 5 -methylthioadenosine transport across the human erythrocyte plasma membrane.
- To differentiate between MTA transport and its intracellular metabolic trapping.
Main Methods:
- Utilized phosphate-depleted human erythrocytes to isolate transport from metabolism.
- Employed [14C]-labelled 5 -methylthioadenosine for uptake studies.
- Applied newly developed High-Performance Liquid Chromatography (HPLC) techniques for intracellular analysis of MTA and its metabolites.
Main Results:
- Identified a carrier-mediated transport system for 5 -methylthioadenosine with a Km of approximately 3 mM and Vmax of approximately 600 pmol/10(6) cells/min.
- Demonstrated that in the presence of phosphate, MTA uptake exceeds equilibrium due to its conversion to 5-methylthioribose-1-phosphate by 5 -methylthioadenosine phosphorylase.
- Quantified intracellular MTA and its metabolites using HPLC.
Conclusions:
- The transport of 5 -methylthioadenosine in human erythrocytes is a carrier-mediated process.
- Metabolic conversion of 5 -methylthioadenosine significantly influences its intracellular accumulation.
- Advanced HPLC methods enable precise analysis of MTA transport and metabolism.